shortagewatch

Home / Metformin / Czechia

CZ ATC A10BA02 · updated 2 Nov 2026

Metformin shortage in Czechia

Is there a Metformin shortage in Czechia?

Yes. As of 2 Nov 2026, 12 Metformin products are reported short in Czechia, the first since 22 Jan 2026. The company estimate for the return is 16 Nov 2026 (latest 16 Apr 2027). Main reason: manufacturing problem.

Also short in Canada, Italy, Spain, Belgium, Sweden, Japan, Australia. All countries.

Affected products in Czechia

CountryProductCompanySinceExpected backReason
CZMETFORMIN TEVA 500MG 500MG TBL FLM 60Teva Pharmaceuticals CR, s.r.o., Praha22 Jan 202631 Jan 2027Manufacturing problem
Výrobní důvody
CZMETFORMIN TEVA 850MG 850MG TBL FLM 60Teva Pharmaceuticals CR, s.r.o., Praha28 Feb 2026not givenManufacturing problem
Výrobní důvody
CZMETFORMIN TEVA XR 1000MG 1000MG TBL PRO 60Teva B.V., Haarlem22 Jun 2026not givenManufacturing problem
Výrobní důvody
CZMETFORMIN VIATRIS 850MG 850MG TBL FLM 120VIATRIS LIMITED, Dublin1 Aug 202631 Dec 2026Manufacturing problem
Výrobní důvody
CZMETFORMIN TEVA 1000MG 1000MG TBL FLM 60 IITeva Pharmaceuticals CR, s.r.o., Praha4 Sep 2026not givenManufacturing problem
Výrobní důvody
CZSIOFOR PROLONG 1000MG 1000MG TBL PRO 60Menarini12 Oct 202616 Nov 2026Manufacturing problem
Výrobní důvody
CZMETFORMIN SANDOZ 1000MG 1000MG TBL PRO 60Sandoz s.r.o., Praha2 Nov 202616 Apr 2027Manufacturing problem
Výrobní důvody
CZMETFORMIN SANDOZ 500MG 500MG TBL PRO 60Sandoz s.r.o., Praha2 Nov 202616 Apr 2027Manufacturing problem
Výrobní důvody
CZMETFORMIN SANDOZ 750MG 750MG TBL PRO 60Sandoz s.r.o., Praha2 Nov 202616 Apr 2027Manufacturing problem
Výrobní důvody
CZMETFORMIN TEVA XR 500MG 500MG TBL PRO 60 I anticipatedTeva Pharmaceuticals CR, s.r.o., Praha6 Nov 202631 Dec 2026Manufacturing problem
Výrobní důvody
CZMETFORMIN TEVA XR 750MG 750MG TBL PRO 60 anticipatedTeva B.V., Haarlem30 Nov 202631 Jan 2027Manufacturing problem
Výrobní důvody
CZMETFORMIN TEVA 850MG 850MG TBL FLM 30 anticipatedTeva Pharmaceuticals CR, s.r.o., Praha8 Dec 202628 Feb 2027Manufacturing problem
Výrobní důvody

Source

SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.